Related Experiment Video
Updated: Jul 17, 2025
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Drug Repurposing Analysis for Colorectal Cancer through Network Medicine Framework: Novel Candidate Drugs and Small
1Department of Bioengineering, Adana Alparslan Türkeş Science and Technology University, Adana, Turkey.
Abstract:
This study aimed to reveal the drug-repurposing candidates for colorectal cancer (CRC) via drug-repurposing methods and network biology approaches. A novel, differentially co-expressed, highly interconnected, and co-regulated prognostic gene module was identified for CRC. Based on the gene module, polyethylene glycol (PEG), gallic acid, pyrazole, cordycepin, phenothiazine, pantoprazole, cysteamine, indisulam, valinomycin, trametinib, BRD-K81473043, AZD8055, dovitinib, BRD-A17065207, and tyrphostin AG1478 presented as drugs and small molecule candidates previously studied in the CRC. Lornoxicam, suxamethonium, oprelvekin, sirukumab, levetiracetam, sulpiride, NVP-TAE684, AS605240, 480743.cdx, HDAC6 inhibitor ISOX, BRD-K03829970, and L-6307 are proposed as novel drugs and small molecule candidates for CRC.
Insights
This study identifies novel drug candidates for colorectal cancer (CRC) using network biology. It proposes existing and new small molecules for CRC treatment, offering new therapeutic avenues.
Area of Science:
- Oncology
- Pharmacology
- Bioinformatics
Background:
- Colorectal cancer (CRC) remains a significant health challenge.
- Effective drug-repurposing strategies are crucial for developing new CRC therapies.
- Network biology offers powerful tools for identifying therapeutic targets.
Purpose of the Study:
- To identify potential drug-repurposing candidates for colorectal cancer (CRC).
- To leverage network biology approaches for novel therapeutic discoveries in CRC.
- To uncover both previously studied and novel small molecules for CRC treatment.
Main Methods:
- Utilized drug-repurposing methodologies.
- Employed network biology approaches to analyze gene expression data.
- Identified a novel, prognostic gene module specific to CRC.
Main Results:
- A prognostic gene module for colorectal cancer was identified.
- Several known drugs and small molecules were confirmed as CRC candidates (e.g., polyethylene glycol, trametinib).
- Novel drug and small molecule candidates for CRC were proposed (e.g., Lornoxicam, HDAC6 inhibitor ISOX).
Conclusions:
- The study successfully identified a prognostic gene module for CRC.
- Network biology and drug-repurposing approaches can reveal effective CRC therapeutics.
- The proposed candidates warrant further investigation for CRC treatment.
